• FirefoxInstall the new Firefox »
  •  Dow Down 0.53% Nasdaq Down 0.18%

    Anika Therapeutics Inc. (ANIK)

    -NasdaqGS
    39.50 Down 0.46(1.15%) 9:33AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:39.96
    Open:N/A
    Bid:38.50 x 300
    Ask:44.90 x 100
    1y Target Est:49.25
    Beta:2.18
    Earnings Date:Apr 27 - May 1 (Est.)
    Day's Range:39.50 - 39.97
    52wk Range:34.16 - 51.40
    Volume:2,243
    Avg Vol (3m):160,972
    Market Cap:584.60M
    P/E (ttm):15.74
    EPS (ttm):2.51
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ANIK

    Comparison

    Symbol% ChgMkt Cap
    ANIKDown 1.15%584.60M
    AGNDown 0.23%70.52B

    Key Statistics

    Forward P/E (1 yr):22.45
    P/S (ttm):5.60
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :1.51
    Quarterly EPS Est (Mar-15) :0.23
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):0.87

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair in the United States, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback